# OnCo record canariabio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/canariabio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "canariabio" ;
  schema:name "CanariaBio"@en ;
  schema:alternateName "OncoQuest"@en, "OncoQuest Pharmaceuticals"@en, "카나리아바이오"@en ;
  schema:description "CanariaBio is a South Korean biotech that took over oregovomab, an antibody against the ovarian cancer marker CA-125 that is given with chemotherapy to prime an immune response against the tumour."@en ;
  schema:url <https://onco.cc/companies/canariabio/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "KR" ;
  onco:drugs <https://onco.cc/drugs/oregovomab/> .